Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPOX | P50336 | 16/20 | 0.79 |
| ▸ | MEN1 | O00255 | 2/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.79 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.79 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39055 | 0.93 | PPOX (0.65) | PPOXMEN1KMT2ATDP1NR1I2 | |
| SCHEMBL29635318 | 0.93 | PPOX (0.65) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Isopropylamine SCHEMBL19641800 | 0.92 | PPOX (0.66) | PPOXMEN1KMT2ATDP1NR1I2 | |
| SCHEMBL28435013 | 0.92 | PPOX (0.64) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL27754194 | 0.90 | PPOX (0.89) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Acetone SCHEMBL532802 | 0.89 | PPOX (0.61) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL1068568 | 0.89 | PPOX (1.00) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL29423792 | 0.89 | PPOX (1.00) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL38813 | 0.89 | PPOX (1.00) | PPOXMEN1KMT2ATDP1NR1I2 | |
| Oxadiazon SCHEMBL21633846 | 0.88 | PPOX (0.98) | PPOXMEN1KMT2ATDP1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11547113-B2 | Liquid polymer suspensions | RHODIA OPERATIONS (FR) | 2023-01-10 | — | — | US | disclosed |
| EP-2916652-A1 | LIQUID POLYMER SUSPENSIONS | Rhodia Operations (FR) | 2015-09-16 | — | — | EP | disclosed |
| US-20150250165-A1 | LIQUID POLYMER SUSPENSIONS | SPECIALTY OPERATIONS FRANCE (FR) | 2015-09-10 | — | — | US | disclosed |
| WO-2014072429-A1 | LIQUID POLYMER SUSPENSIONS | RHODIA OPERATIONS (FR) | 2014-05-15 | — | — | WO | disclosed |
| EP-2001830-A1 | GLYCERIDE ESTER DERIVATIVES OF HERBICIDAL COMPOUNDS AND COMPOSITIONS THEREOF | NUFARM AUSTRALIA LIMITED (AU) | 2008-12-17 | — | — | EP | disclosed |
| WO-2007112505-A1 | GLYCERIDE ESTER DERIVATIVES OF HERBICIDAL COMPOUNDS AND COMPOSITIONS THEREOF | NUFARM AUSTRALIA LIMITED (AU) | 2007-10-11 | — | — | WO | disclosed |
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | PPOX 1/4885MEN1 4274/4885KMT2A 2099/4885 |
| US-20150250165-A1 | LIQUID POLYMER SUSPENSIONS | ALG1, ALG3, MUC1 | PPOX 3741/4885MEN1 2276/4885KMT2A 1733/4885 |
| US-11547113-B2 | Liquid polymer suspensions | ALG1, ALG3, MUC1 | PPOX 3741/4885MEN1 2276/4885KMT2A 1733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.